Efficacy and Safety of MAA868 in Patients With Atrial Fibrillation (Q59276346)
Jump to navigation
Jump to search
Clinical Trial
- NCT03398434
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and Safety of MAA868 in Patients With Atrial Fibrillation |
Clinical Trial |
|
Statements
Efficacy and Safety of MAA868 in Patients With Atrial Fibrillation (English)
0 references
A Multicenter, Randomized, Open-label, Active-controlled, Dose-range Finding Study to Assess the Pharmacodynamic Parameters, Safety and Tolerability of MAA868 and Its Effect on Thrombogenesis Biomarkers Compared to Apixaban in Patients With Atrial Fibrillation (English)
0 references
1 reference
29 November 2018
16 October 2018
0 references
30 January 2020
0 references
55 year
0 references
85 year
0 references